Source: Cancer Network, May 2019 There was no difference in health-related quality of life among patients with resected stage III melanoma with BRAF mutations treated with adjuvant dabrafenib plus trametinib and those assigned to placebo, according to a patient-reported outcomes analysis of the COMBI-AD study. “Our findings provide evidence that adjuvant dabrafenib plus trametinib did not have […]
Posted in Melanoma News, Health Professionals, Of Interest
Source: Do Wire, May 2019 A study published in the Journal of the National Cancer Institute found that indoor tanning bed exposure may trigger a specific genetic mutation, BRAF V600E, associated with melanoma and contribute to younger age at diagnosis. Researchers assessed 114 patients who used indoor tanning beds and 222 who did not between December 2013 and May 2015.
Posted in Melanoma News, Health Professionals, Patients, Latest News, Of Interest
Source: Optometry Today, May 2019 Scientists from the University of Surrey and Royal Surrey County Hospital have reported on a new approach to treating melanoma-associated retinopathy (MAR) in JAMA Ophthalmology. With the support of Moorfields Eye Hospital’s electrophysiology department, the researchers investigated whether long acting steroid implants could improve vision in a 73-year-old patient with MAR. […]
Posted in Melanoma News, Health Professionals, Clinical Trials
Source: WebMd, May 2019 May 6, 2019 — As melanoma cases continue to rise sharply, Americans are being urged to get screened early for this deadliest of skin cancers. But some dermatologists question whether screening people without symptoms has resulted in overdiagnosing melanoma, bringing unnecessary anxiety and treatments. They note that while the number of invasive melanoma cases diagnosed in […]
Posted in Melanoma News, Patients, Latest News
